Respuesta inmune innata y adaptativa frente al SARS-CoV-2. Diagnóstico: PCR y serología / Innate and adaptive immune response against SARS-CoV-2. Diagnosis: PCR and serology
Rev. Hosp. Clin. Univ. Chile
;
32(2): 118-128, 2021. graf
Article
in Spanish
| LILACS
| ID: biblio-1344679
ABSTRACT
SARS-CoV-2 infection in the people has been characterized by great variability in the clinical manifestations, ranging from an asymptomatic infection in some individuals to a fatal disease in others. Recently, the importance of human genetics in determining clinical response has been highlighted. Within this context there are patients who don't become infected despite viral exposure and others who, being young without comorbidities, develop a severe disease. On the other hand, it's under constant investigation whether the presence of a concomitant primary or secondary immunodeficiency determines a different clinical course. (AU)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
SARS-CoV-2
Type of study:
Diagnostic study
Limits:
Humans
Language:
Spanish
Journal:
Rev. Hosp. Clin. Univ. Chile
Journal subject:
Medicine
Year:
2021
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital Clínico de la Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS